The Covid-19 pandemic has had a significant impact on global healthcare systems, particularly for vulnerable populations such as patients with chronic kidney disease (CKD). Mumbai, a densely populated city in India, has faced immense challenges in managing the healthcare needs of its CKD patients during the pandemic. This study aims to assess the burden of Covid-19 on CKD patients in Mumbai and evaluate the associated clinical outcomes.

Covid-19, chronic kidney disease, hospitalization

Cheng Y, Luo R, Wang K, et al. Kidney disease is associated with in-hospital death of patients with COVID-19.

Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China.

Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol.

Lui SL, Ng MY, Ip F, et al. COVID-19 in CKD and dialysis patients. Clin J Am Soc Nephrol.

Remuzzi A, Remuzzi G. COVID-19 and Italy: what next? Lancet.

Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA.

Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA.

Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med.